Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1371745 | Bioorganic & Medicinal Chemistry Letters | 2010 | 4 Pages |
Abstract
A series of N-(2-amino-5-substituted phenyl)benzamides (3–21) were designed, synthesized and evaluated for their inhibition of HDAC2 and their cytotoxicity in HCT116 cancer cells. Multiple compounds from this series demonstrated time-dependent binding kinetics that is rationalized using a co-complex crystal structure of HDAC2 and N-(4-aminobiphenyl-3-yl)benzamide (6).
Graphical abstractSubstituted N-(2-aminophenyl)benzamides demonstrated time-dependent binding kinetics that is rationalized using a co-complex crystal structure of HDAC2 and N-(4-aminobiphenyl-3-yl)benzamide (6).Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Jerome C. Bressi, Andy J. Jennings, Robert Skene, Yiqin Wu, Robert Melkus, Ron De Jong, Shawn O’Connell, Charles E. Grimshaw, Marc Navre, Anthony R. Gangloff,